• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
SARS-CoV-2 Viral Load, IFNλ Polymorphisms and the Course of COVID-19: An Observational Study.严重急性呼吸综合征冠状病毒2型病毒载量、干扰素λ基因多态性与冠状病毒病2019的病程:一项观察性研究
J Clin Med. 2020 Oct 15;9(10):3315. doi: 10.3390/jcm9103315.
2
PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19.PNPLA3和TLL-1基因多态性作为COVID-19患者疾病严重程度的潜在预测指标
Front Cell Dev Biol. 2021 Jun 23;9:627914. doi: 10.3389/fcell.2021.627914. eCollection 2021.
3
The association between interferon lambda 3 and 4 gene single-nucleotide polymorphisms and the recovery of COVID-19 patients.干扰素 lambda 3 和 4 基因单核苷酸多态性与 COVID-19 患者康复的关系。
Virol J. 2021 Nov 14;18(1):221. doi: 10.1186/s12985-021-01692-z.
4
Association of Interferon Lambda 3 and 4 Gene SNPs and Their Expression with COVID-19 Disease Severity: A Cross-Sectional Study.干扰素λ3和4基因单核苷酸多态性及其表达与COVID-19疾病严重程度的关联:一项横断面研究
Infect Drug Resist. 2023 Oct 10;16:6619-6628. doi: 10.2147/IDR.S422095. eCollection 2023.
5
IFNL3/4 polymorphisms as a two-edged sword: An association with COVID-19 outcome.IFNL3/4基因多态性:一把双刃剑,与新冠病毒疾病结局的关联
J Med Virol. 2023 Feb;95(2):e28506. doi: 10.1002/jmv.28506.
6
Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load.黏膜基因表达对 SARS-CoV-2 反应与病毒载量相关。
J Virol. 2023 Feb 28;97(2):e0147822. doi: 10.1128/jvi.01478-22. Epub 2023 Jan 19.
7
Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study.干扰素 lambda 4 基因多态性 rs368234815 与血液透析患者丙型肝炎病毒自发清除的关系:一项病例对照研究。
BMC Infect Dis. 2021 Jan 22;21(1):102. doi: 10.1186/s12879-021-05777-6.
8
Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity.SARS-CoV-2 G614 感染(武汉株)患者新冠病毒载量随症状出现和严重程度的变化轨迹。
JAMA Netw Open. 2022 Jan 4;5(1):e2142796. doi: 10.1001/jamanetworkopen.2021.42796.
9
SARS-CoV-2 quantitative real time PCR and viral loads analysis among asymptomatic and symptomatic patients: an observational study on an outbreak in two nursing facilities in Campania Region (Southern Italy).无症状和有症状患者中新型冠状病毒2型定量实时聚合酶链反应及病毒载量分析:对坎帕尼亚大区(意大利南部)两家护理机构疫情的一项观察性研究
Infect Agent Cancer. 2021 Jun 22;16(1):45. doi: 10.1186/s13027-021-00388-x.
10
Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.无症状、轻度和重症有症状 SARS-CoV-2 感染患者的病毒载量、淋巴细胞亚群和细胞因子:一项回顾性研究。
Virol J. 2021 Jun 12;18(1):126. doi: 10.1186/s12985-021-01597-x.

引用本文的文献

1
The common genetic variant rs1278960 determining expression of Interferon-lambda predicts inflammatory response in critically ill COVID-19 patients.决定干扰素-λ表达的常见基因变异rs1278960可预测危重症COVID-19患者的炎症反应。
Sci Rep. 2025 May 6;15(1):15802. doi: 10.1038/s41598-025-91628-2.
2
FURIN, IFNL4, and TLR2 gene polymorphisms in relation to COVID-19 severity: a case-control study in Egyptian patients.弗林蛋白酶、IFNL4和TLR2基因多态性与新型冠状病毒肺炎严重程度的关系:埃及患者的病例对照研究
Infection. 2024 Dec;52(6):2213-2229. doi: 10.1007/s15010-024-02266-1. Epub 2024 May 4.
3
Association of genetic polymorphisms with COVID-19 infection and outcomes: An updated meta-analysis based on 62 studies.基因多态性与新型冠状病毒肺炎感染及预后的关联:基于62项研究的最新荟萃分析
Heliyon. 2023 Dec 14;10(1):e23662. doi: 10.1016/j.heliyon.2023.e23662. eCollection 2024 Jan 15.
4
Association of Interferon Lambda 3 and 4 Gene SNPs and Their Expression with COVID-19 Disease Severity: A Cross-Sectional Study.干扰素λ3和4基因单核苷酸多态性及其表达与COVID-19疾病严重程度的关联:一项横断面研究
Infect Drug Resist. 2023 Oct 10;16:6619-6628. doi: 10.2147/IDR.S422095. eCollection 2023.
5
Potential of Interferon Lambda as an Inhibitor of SARS-CoV-2.干扰素λ作为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抑制剂的潜力
Mol Biol. 2023;57(2):291-298. doi: 10.1134/S0026893323020152. Epub 2023 Apr 26.
6
The effect of ACE2 receptor, IFN-γ, and TNF-α polymorphisms on the severity and prognosis of the disease in SARS-CoV-2 infection.ACE2 受体、IFN-γ 和 TNF-α 多态性对严重急性呼吸综合征冠状病毒 2 感染疾病严重程度和预后的影响。
J Investig Med. 2023 Jun;71(5):526-535. doi: 10.1177/10815589231158379. Epub 2023 Mar 6.
7
Association between SARS-CoV-2 Viral Load and Patient Symptoms and Clinical Outcomes Using Droplet Digital PCR.利用数字液滴 PCR 技术检测 SARS-CoV-2 病毒载量与患者症状及临床结局的相关性。
Viruses. 2023 Feb 5;15(2):446. doi: 10.3390/v15020446.
8
Polymorphisms in , , , , and Genes Are Associated with Worse Clinical Outcomes in COVID-19.基因、、、和中的多态性与 COVID-19 的临床结局恶化相关。
Genes (Basel). 2022 Dec 22;14(1):29. doi: 10.3390/genes14010029.
9
Genetics of COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review.新冠病毒和肌痛性脑脊髓炎/慢性疲劳综合征的遗传学:系统综述。
Ann Clin Transl Neurol. 2022 Nov;9(11):1838-1857. doi: 10.1002/acn3.51631. Epub 2022 Oct 6.
10
Bimodal distribution pattern associated with the PCR cycle threshold (Ct) and implications in COVID-19 infections.与 PCR 循环阈值 (Ct) 相关的双峰分布模式及其对 COVID-19 感染的影响。
Sci Rep. 2022 Aug 25;12(1):14544. doi: 10.1038/s41598-022-18735-2.

本文引用的文献

1
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020.2019新型冠状病毒病(COVID-19)疫情的流行病学特征 - 中国,2020年
China CDC Wkly. 2020 Feb 21;2(8):113-122.
2
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.COVID-19 危重症患者体内针对 I 型干扰素的自身抗体。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4585. Epub 2020 Sep 24.
3
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.COVID-19 危重症患者的 I 型 IFN 免疫先天缺陷。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4570. Epub 2020 Sep 24.
4
Presence of Genetic Variants Among Young Men With Severe COVID-19.年轻男性严重 COVID-19 患者中存在遗传变异。
JAMA. 2020 Aug 18;324(7):663-673. doi: 10.1001/jama.2020.13719.
5
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.新型冠状病毒病 2019(COVID-19)的病理生理学、传播、诊断和治疗:综述。
JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839.
6
SARS-CoV-2 detection, viral load and infectivity over the course of an infection.在感染过程中对 SARS-CoV-2 的检测、病毒载量和传染性。
J Infect. 2020 Sep;81(3):357-371. doi: 10.1016/j.jinf.2020.06.067. Epub 2020 Jun 29.
7
Considering how biological sex impacts immune responses and COVID-19 outcomes.考虑到生物性别如何影响免疫反应和 COVID-19 的结果。
Nat Rev Immunol. 2020 Jul;20(7):442-447. doi: 10.1038/s41577-020-0348-8. Epub 2020 Jun 11.
8
Impact of sex and gender on COVID-19 outcomes in Europe.欧洲 COVID-19 结局的性别差异。
Biol Sex Differ. 2020 May 25;11(1):29. doi: 10.1186/s13293-020-00304-9.
9
Gender differences in patients with COVID-19: a narrative review.2019冠状病毒病患者的性别差异:一项叙述性综述
Monaldi Arch Chest Dis. 2020 May 25;90(2). doi: 10.4081/monaldi.2020.1389.
10
A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection.全球努力定义 SARS-CoV-2 感染保护性免疫的人类遗传学。
Cell. 2020 Jun 11;181(6):1194-1199. doi: 10.1016/j.cell.2020.05.016. Epub 2020 May 13.

严重急性呼吸综合征冠状病毒2型病毒载量、干扰素λ基因多态性与冠状病毒病2019的病程:一项观察性研究

SARS-CoV-2 Viral Load, IFNλ Polymorphisms and the Course of COVID-19: An Observational Study.

作者信息

Amodio Emanuele, Pipitone Rosaria Maria, Grimaudo Stefania, Immordino Palmira, Maida Carmelo Massimo, Prestileo Tullio, Restivo Vincenzo, Tramuto Fabio, Vitale Francesco, Craxì Antonio, Casuccio Alessandra

机构信息

Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.

Department of Medicine, ARNAS Civico, Unità Operativa Malattie Infettive, 90127 Palermo, Italy.

出版信息

J Clin Med. 2020 Oct 15;9(10):3315. doi: 10.3390/jcm9103315.

DOI:10.3390/jcm9103315
PMID:33076493
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7602550/
Abstract

The course of SARS-CoV-2 infection ranges from asymptomatic to a multiorgan disease. In this observational study, we investigated SARS-CoV-2 infected subjects with defined outcomes, evaluating the relationship between viral load and single nucleotide polymorphisms of genes codifying for IFNλs (interferon). The study enrolled 381 patients with laboratory-confirmed SARS-CoV-2 infection. For each patient, a standardized form was filled including sociodemographic variables and clinical outcomes. The host's gene polymorphisms (IFNL3 rs1297860 C/T and INFL4 rs368234815 TT/ΔG) and RtReal-Time PCR cycle threshold (PCR Ct) value on SARS-CoV-2 were assessed on nasal, pharyngeal or nasopharyngeal swabs. Higher viral loads were found in patients aged > 74 years and homozygous mutant polymorphisms DG in IFNL4 (adj-OR = 1.16, 95% CI = 1.01-1.34 and adj-OR = 1.24, 95% CI = 1.09-1.40, respectively). After adjusting for age and sex, a statistically significantly lower risk of hospitalization was observed in subjects with higher RtReal-Time PCR cycle threshold values (adj-OR = 0.95, 95% CI = 0.91, 0.99; = 0.028). Our data support the correlation between SARS-CoV-2 load and disease severity, and suggest that IFNλ polymorphisms could affect the ability of the host to modulate viral infection without a clear impact on the outcome of COVID-19.

摘要

新型冠状病毒2型(SARS-CoV-2)感染的病程范围从无症状到多器官疾病。在这项观察性研究中,我们调查了具有明确结局的SARS-CoV-2感染受试者,评估病毒载量与编码干扰素λ(IFNλs)基因的单核苷酸多态性之间的关系。该研究纳入了381例实验室确诊的SARS-CoV-2感染患者。为每位患者填写了一份标准化表格,包括社会人口统计学变量和临床结局。在鼻拭子、咽拭子或鼻咽拭子上评估宿主的基因多态性(IFNL3 rs1297860 C/T和INFL4 rs368234815 TT/ΔG)以及SARS-CoV-2的逆转录实时荧光定量PCR循环阈值(PCR Ct)值。在年龄>74岁且IFNL4基因纯合突变多态性为DG的患者中发现了更高的病毒载量(校正比值比分别为1.16,95%置信区间为1.01-1.34和1.24,95%置信区间为1.09-1.40)。在调整年龄和性别后,观察到逆转录实时荧光定量PCR循环阈值较高的受试者住院风险在统计学上显著降低(校正比值比=0.95,95%置信区间为0.91,0.99;P=0.028)。我们的数据支持SARS-CoV-2载量与疾病严重程度之间的相关性,并表明IFNλ多态性可能影响宿主调节病毒感染的能力,但对2019冠状病毒病(COVID-19)的结局没有明显影响。